CME CEO Plans to Sue CFTC Over Perpetual Futures Approval

On June 18, 2026, CME Group Chief Executive Terrence Duffy confirmed the company's intention to file a lawsuit against the U.S. Commodity Futures Trading Commission (CFTC). This legal action follows the CFTC's recent approval of perpetual futures products offered by Kalshi, a move Duffy argues contradicts stipulations in the Dodd-Frank Act.

Duffy contends that under the Dodd-Frank Act, the definition of a swap — a financial agreement in which two parties exchange cash flows or payments — should exclude the futures products approved by the CFTC. "Under the Dodd-Frank Act, it clearly defines what a swap is and what a future is...these products that he supposedly approved as futures are not futures, they would be swaps," he remarked.

He further emphasized that the requirements for participating in the swap market are notably distinct from those for futures trading. This distinction raises significant concerns about the regulatory framework guiding these financial instruments. Duffy stated that CME will await clearer rules before considering introducing its own perpetual futures contracts, but currently, he finds the regulations to be ambiguous. Duffy expressed concerns about the CFTC potentially misrepresenting facts, particularly referencing their statements regarding continuous trading setups as enforceable rules.

The implications of this lawsuit could be substantial, as the CFTC's role in regulating futures and swaps significantly impacts the broader derivatives market. Regulatory clarity is essential for both providers and participants in this rapidly evolving sector.

As the lawsuit will likely unfold over time, industry observers will need to monitor further developments from the CFTC and whether other companies may consider similar legal actions. The outcome could set significant precedents for how perpetual futures and swap-like products are classified and regulated in the U.S.